![]() | |
| | #1 (permalink) |
| Under Construction Join Date: May 2004 Posts: 25 Rep Power: ![]() | Im getting these Androstene tablets, basically what I wanted to know was how I should take these, each one is 100mg, and I want to know when I should take them during the day. What about a training routine, what do you suggest, 5-6 days a week and what about calorie consumption. |
| | |
| | #2 (permalink) |
| Making Progress Join Date: Oct 2004 Location: Warrington, Cheshire Posts: 184 Rep Power: ![]() | For training I'd say stick to what your currently doing, I know people who take steroids off other boards and they dont change there routines and there very experianced users! ______________________ Benj |
| | |
| | #3 (permalink) |
| Making Progress Join Date: Oct 2004 Location: USA Posts: 372 Rep Power: ![]() | yeah your training should be in check long before you think about taking pro-hormones or steroids. that way you don't have to learn a new game along w/ the gear. I'm not sure which andro you have... is it androstenedione, 4-androstenediol, 1-androstenediol, 5-androstenedione/diol? this makes a difference when figuring out the doses ______________________ thricefan@cyber-rights.net You have to do what others won't to achieve what others don't. |
| | |
| | #4 (permalink) |
| whilst i definately agree your training should be very advanced before u attempt to use any ph or steds u can definately increase the volume of ure training whilst on cycle bcoz u dont have to worry so much about overtraining and then decrease ure volume of training during pct as ure not attempting to improve in this period just maintain ure gains 5/6 time a week should be fine try to aim for around 8 hours in the weights room a week IMO althou swole is a far more experienced user than myself so listen to his advice. ______________________ In This country you gotta make the money 1st, then when u get the money, u get the power, then when u get the power, u get the woman. | |
| | |
![]() |
| Bookmarks |
| Thread Tools | |
| Display Modes | |
| |